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Introduction
Huntington's disease (HD) is a highly debilitating, autosomal-dominant neurodegenerative disorder characterized by motor dysfunction, behavioral abnormalities, and cognitive decline 1 . In HD, an expanded CAG repeat generates a pathogenic polyglutamine tract near the N-terminus of Huntingtin (HTT). Expansion of this polyglutamine tract confers a toxic gain of function to HTT 2 . Furthermore, though HTT is universally expressed, HD is characterized by selective neuropathological changes including atrophy of the caudate and putamen with prominent vulnerability of the striatal medium spiny neurons (MSNs) 3 .
Although mechanisms of neurodegeneration in HD are still under investigation, several classes of neuronal stress have been implicated in its pathogenesis, including oxidative stress, mitochondrial dysfunction, glutamine sensitivity, and metabolic dysregulation 4 . Congruently, many environmental toxicants are also known to elicit similar types of neuronal stress, such as the pro-oxidant metal manganese (Mn), which causes striatal neurotoxicity in excess 5, 6 . MSNs in the striatum exhibit disruptions in neurochemistry and morphology in the context of Mn exposure 7 . HD genotype prevents characteristic increases in MSN total dendritic length and branching found from week 13-16 in mouse postnatal development, and decreases in total spine density at week 16 of age 7 . These pathophysiological changes in MSNs coincide with the onset hyperkinetic behavioral abnormalities observed in mouse models of HD 8 . While the mechanism underlying disruptions in synaptic morphology that generate behavioral phenotypes is poorly understood, it has been proposed that downstream alterations in neuron connectivity and excitability impact signal propagation for higher functions [9] [10] [11] [12] [13] . Mouse models of HD exhibit disruptions in dopaminergic signaling [14] [15] [16] exposure conditions (Fig. 1) . Given that normal levels of brain Mn in mammals range from 20-53µM, we sought to assess the ability of Mn to influence the metabolic profile at low (0µM Mn added), moderate non-toxic (31µM Mn), and high toxicological exposure concentrations (125µM Mn) 23 . These concentrations reflect over a 17-fold change in cellular Mn levels, ranging from ~5 to ~90 fmol Mn/100 cells with mutant cells accumulating less Mn than wild type cells consistent with our previous studies 21, 22 (Fig. 2 ). An untargeted assessment of intracellular metabolic perturbations was performed through a comprehensive small molecule profiling approach that integrates metabolomics, lipidomics, and glycomics, using ultra-performance liquid chromatography-ion mobility-mass spectrometry (UPLC-IM-MS) [24] [25] [26] [27] [28] [29] [30] injections of the quality control. Quality control injections were then performed after every 10th sample injection to ensure instrument stability.
UPLC-IM-MS/MS
Continuous IM-MS E spectra were acquired at a rate of 2 Hz from 50-2000 Da in positive mode for the duration of the injection. The instrument was calibrated to less than 1ppm mass accuracy using sodium formate clusters prior to analysis. A two-point internal standard of leucine Data processing and statistical analysis. Data were converted to mzXML format using the msconvert tool from the ProteoWizard package as previously described 34 . Peak picking and alignment were performed using XCMS in R 35 . The resulting data matrix contained 475 detected features. Features were pre-filtered for reproducibility using an ANOVA threshold of p ≤ 0. Pearson's correlation distance metric and random selection initialization was used. Further statistical analyses were performed in SPSS version 22 (SPSS, Inc. Chicago, IL). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
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Metabolite identification. Metabolite identifications were performed using accurate mass measurements and fragmentation spectra extracted from IM-MS E data. Utilizing drift time correlations, product ions were correlated appropriately to precursors for extraction of highenergy spectra. Annotated spectra may be found in the Supporting Information (Fig. S1-S5 ).
Identification confidence levels are in accordance with the Metabolomics Standards Initiative proposed minimum reporting standards 36 . Metabolites were prioritized using the SOM methodology and five were subsequently identified. These putative identifications are supported by accurate mass measurements and fragmentation data interpretation aided through database searching (Table S1 ). Fragmentation data were acquired using the untargeted fragmentation of all ions post-mobility separation, which were subsequently isolated using mobility correlations HD striatal cell lines are driven primarily by the concentration of Mn to which they are exposed.
Principle component analysis (PCA) shows separation of global metabolomic profiles in principal component one (PC1) based upon treatment conditions (Fig. 3) . Each marker represents the average metabolomic profile of one biological sample analyzed in triplicate and ANOVA filtered. Biological replicates cluster in PCA space, indicating biological consistency of these measurements. However, PC2 separates metabolomic profiles predominantly based upon cell genotype, suggesting differences in basal metabolism between the metabolomic profiles of (Fig. 4) that cluster metabolites by covariance were then used to visualize global patterns of metabolite changes between control and HD striatal cells with varying Mn exposures 29, 41 . In this method, metabolites self-assemble into groups in a user-defined grid based upon similarities in abundance profiles using an unsupervised computational process. For example, metabolites that are increased in abundance consistently across biological replicates as a generic response to Mn concentration will be grouped in a region of the SOM space, while metabolites that are produced as a genotype-specific response to Mn concentration will group in a separate, distinct region of SOM space. Experimental groups are then represented as heat maps based upon the abundances of organized metabolites. The number of metabolites seeded in each grid location of the SOM (Fig. 4) is indicated in the metabolite density map, with blue representing one metabolite and red corresponding to 44 metabolites. The largest metabolite abundance occupying the central region of the SOM space corresponded to a small protein with a molecular weight of 8561.6 Da, putatively identified as ubiquitin based upon accurate mass (Fig. S3) . After SOM prioritization and analysis, we observed a decreased production of glutathione (GSH) and pantothenic acid in the STHdh[Q111/Q111] cell line. A general linear model was applied to evaluate significant differences in the abundance of metabolites by genotype, Mn exposure, or genotype by Mn exposure interaction (Fig. 5A-D 
Mn exposure (p <0.001), genotype (p<0.001), and a genotype by Mn exposure interaction effect (p<0.01). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
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Discussion
The novel application of untargeted metabolomic profiling to characterize Mn-dependent cellular responses in an HD striatal cell model highlighted specific alterations in metabolism. These findings support a hypothesis of altered cellular energetics by pathogenic alleles of HTT, varying Mn exposure conditions, and well as HD by Mn interaction effects.
HD striatal cells exhibit lower levels of pantothenic acid and GSH
The identification of lower levels of pantothenic acid (vitamin B5) and GSH in HD striatal cells fits into the complex biology mediating neuronal mitochondrial processes and metal handling.
Notably, disruptions in pantothenic acid levels have been described in a related neurodegenerative disorder, neurodegeneration with brain iron accumulation (NBIA) 42, 43 .
Mutations in pantothenate kinase 2 (PANK2), encoding a neuronal mitochondrial protein responsible for catalyzing the phosphorylation of pantothenic acid to phosphopantothenate, have been identified in one-third of patients with this disorder 44, 45 . This process is critical to the synthesis of coenzyme (CoA), a universal acyl carrier involved in the citric acid cycle and cellular energetics. In addition, pantothenic acid is a necessary co-enzyme for the synthesis of GSH, and has been shown to protect cells from oxidative damage by increasing free GSH levels 46 . Given our observation of decreased pantothenic acid levels relative to control, downstream impaired cellular energetics and exhausted response to oxidative stress could play a role in neurodegeneration observed in HD. Mn neurotoxicity can result from enhanced production of free radicals that are scavenged by GSH and other antioxidants 47 . However, the decreased abundance of GSH and pantothenic acid we observed appear to be independent of cellular Mn burden given the lack of significant Mn-dependent changes. This finding is 
Alterations in levels of ribulose-5 phosphate implicate modulation of the pentose shunt pathway in HD
The pentose shunt pathway functions to regenerate the reducing agent NADPH, which is necessary for biosynthetic processes in the brain, such as synthesis of free fatty acids from acetyl-CoA 49 . The dehydrogenation of glucose 6-phosphate to ribulose 5-phosphate is the ratelimiting step of the pentose shunt pathway. Furthermore, the pentose shunt pathway is induced by p53, a protein known to mediate cellular dysfunction and behavioral abnormalities in HD 50 .
Our data suggest increasing cellular Mn burden results in a corresponding induction of ribulose 5-phosphate, an effect that was exaggerated in HD striatal cells relative to control. This finding
corroborates previous studies that demonstrate HD striatal cell impairments in mitochondrial dynamics and energetics 51, 52 . The genotype-dependent difference was apparent only at the cytotoxic 125µM Mn exposure, while increasing cellular Mn burden from vehicle to 31µM does not significantly increase ribulose 5-phosphate levels. This is consistent with an involvement of 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 HD striatal cells, increased levels of ribulose 5-phosphate may be a cellular response which increases the reduced amount of GSH available for handling oxidative stress.
HD striatal cells exhibit lower abundance and an impaired Mn-dependent increase of isobutyryl carnitine
Isobutyryl carnitine is a product of the acyl-CoA dehydrogenases, mitochondrial enzymes that are involved in the process of metabolism of fatty acids or branched-chain amino acids. In addition to these functions, carnitines have well described roles in the brain including: lipid synthesis, membrane composition, expression modulation, mitochondrial energetics, activation of antioxidant mechanisms, and strengthening cholinergic neurotransmission 53 . Although, increases in isobutyryl carnitine levels have been observed in inborn errors of metabolism such as short chain acyl dehydrogenase deficiency, reduced levels of this metabolite have not been reported in the context of any neurodegenerative disease 54 . Our data reveal genotype, Mn exposure and genotype by Mn interaction effects for levels of isobutyryl carnitine. We observed that Mn exposure induces elevated levels of isobutyryl carnitine in control striatal cells but not the HD mutant cells. As HD striatal cells accumulate significantly less cellular Mn levels versus control cells 12, 26 , the genotype specific effect is likely due to a failure to reach a sufficient level of intracellular Mn. The observation that levels of isobutyryl carnitine increased in control striatal cells only at the highest Mn exposure is consistent with this interpretation. Mn toxicity occurs in part via impairment of mitochondrial function 55, 56 . The increase in this metabolite under conditions of heavy Mn burden may reflect increased reliance on isobutyrl carninitemediated process to generate acetyl-CoA for ATP synthesis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Modeling the HD-Mn striatal cell metabolomics.
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The striatum is a unique region of the brain, linked to both neurodegeneration in HD and Mn neurotoxicity. The application of untargeted metabolomics to elucidate the mechanisms through which control and HD mouse striatal cells respond to low, moderate non-toxic, and high toxicological Mn levels revealed selective alterations in cellular stress responses. Given that the HD genotype disrupts a variety of cellular processes including transcriptional regulation, HD striatal cells may have adapted their metabolism to survive under this genotypic stressor. Their response to the pathogenic processes of mutant HTT may activate compensatory processes that influence Mn toxicity and oxidative stress metabolites (Fig. 6) . In modeling the changes we observe, we postulate that the HD genotype produces a state of chronic oxidative stress, depleting cellular GSH reserves. In response, HD striatal cells have a deficit in pantothenic acid, hampering efforts to replenish the limited GSH levels. A compensatory process may be induced by HD striatal cells, increased reliance on the pentose shunt pathway to regenerate GSH, when cellular Mn burden reaches cytotoxic levels. The exaggerated response to Mn is especially noteworthy given the decreased ability of HD striatal cells to accumulate Mn 21, 22 . The decreased Mn uptake by HD striatal cells may also explain the selective increase of isobutyrl carnitine levels in control cells at toxic Mn levels.
Conclusion
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